22 results
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:01am
are taking action to reduce our environmental impact on many fronts by prioritizing clean energy solutions, progressing toward net-zero targets … of unused ink in the supplier’s printing process, as well as the amount of solvents necessary to clean the printing machine and the amount of waste
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
to our global GHG reduction goals. The project, which became operational in April 2023, will generate enough clean, renewable energy to power our … loss will have profound consequences for human health if impaired ecosystems can no longer provide clean water, energy, food, recreation and other
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
by prioritizing clean energy solutions, progressing toward net-zero targets and working to eliminate greenhouse gas (GHG) emissions from our entire value chain
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:19am
in clean rooms and using artificial intelligence (AI) to streamline the onboarding experience for new colleagues. Our goal is to create more personalized … health. Degrading air quality, increasing scarcity of clean water and other natural resources, waning biodiversity and the impacts of climate change
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:11am
by prioritizing clean energy solutions, progressing toward net-zero targets and working to eliminate greenhouse gas (GHG) emissions from our entire value chain
6-K
7xhaed
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
7rlo2bc q0i
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
1zl2ur ivs72c
28 May 21
Current report (foreign)
6:04am
6-K
EX-99.1
tbkpt6f
17 Dec 20
Current report (foreign)
6:01am
F-3ASR
EX-1.1
3qim7
24 Jun 20
Automatic shelf registration (foreign)
4:30pm
6-K
EX-99.1
kwpxyk
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
20FR12B/A
EX-10.14
lb5kf
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.7
3t64 dydu2
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.5
nwc2g710 k8
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.9
s5puomqd44n9j
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
EX-10.5
ypwxea3caaz
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B
EX-10.7
6ycbz7dm ra2bduq
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B
EX-10.9
8sc26aqpsnk
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B
EX-10.14
tm3fw
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
EX-10.7
qyg024p6 tn8
16 Nov 18
Draft registration statement (amended)
12:00am